메뉴 건너뛰기




Volumn 11, Issue , 2011, Pages

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHLORAMPHENICOL; CHLORAMPHENICOL ACETYLTRANSFERASE; RECOMBINANT ENDOLYSIN DEFICIENT STAPHYLOCOCCUS AUREUS PHAGE P954; TROMETAMOL; UNCLASSIFIED DRUG; ENDOLYSIN; PROTEINASE; VIRUS PROTEIN;

EID: 80052151543     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-195     Document Type: Article
Times cited : (69)

References (35)
  • 1
    • 0030847064 scopus 로고    scopus 로고
    • Bacteriophage therapy and prophylaxis: Rediscovery and renewed assessment of potential
    • DOI 10.1016/S0966-842X(97)01054-8, PII S0966842X97010548
    • Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Barrow PA, Soothill JS, Trends Microbiol 1997 5 268 271 10.1016/S0966-842X(97)01054-8 9234508 (Pubitemid 27314514)
    • (1997) Trends in Microbiology , vol.5 , Issue.7 , pp. 268-271
    • Barrow, P.A.1    Soothill, J.S.2
  • 2
    • 0347694965 scopus 로고    scopus 로고
    • Set a Microbe to Kill a Microbe: Drug Resistance Renews Interest in Phage Therapy
    • DOI 10.1001/jama.290.24.3183
    • Set a microbe to kill a microbe: Drug resistance renews interest in phage therapy. Thacker PD, JAMA 2003 290 3183 3185 10.1001/jama.290.24.3183 14693857 (Pubitemid 38020673)
    • (2003) Journal of the American Medical Association , vol.290 , Issue.24 , pp. 3183-3185
    • Thacker, P.D.1
  • 3
    • 4344650341 scopus 로고    scopus 로고
    • Therapeutic use of bacteriophages
    • DOI 10.1016/S1473-3099(04)01127-2, PII S1473309904011272
    • Therapeutic use of bacteriophages. Soothill JS, Hawkins C, Anggard EA, Harper DR, Lancet Infectious Diseases 2004 4 544 545 15336219 (Pubitemid 39141794)
    • (2004) Lancet Infectious Diseases , vol.4 , Issue.9 , pp. 544-545
    • Soothill, J.1    Hawkins, C.2    Anggard, E.3    Harper, D.4
  • 4
    • 33750715724 scopus 로고    scopus 로고
    • FDA approves use of bacteriophages to be added to meat and poultry products
    • 17067600
    • FDA approves use of bacteriophages to be added to meat and poultry products. Lang L, Gastroenterology 2006 131 1370 1372 17067600
    • (2006) Gastroenterology , vol.131 , pp. 1370-1372
    • Lang, L.1
  • 5
    • 0034769921 scopus 로고    scopus 로고
    • Bacteriophage therapy
    • DOI 10.1146/annurev.micro.55.1.437
    • Bacteriophage therapy. William Summers C, Annu Rev Microbiol 2001 55 437 451 10.1146/annurev.micro.55.1.437 11544363 (Pubitemid 32978113)
    • (2001) Annual Review of Microbiology , vol.55 , pp. 437-451
    • Summers, W.C.1
  • 6
    • 0026800935 scopus 로고
    • Bacteriophage lysis: Mechanism and regulation
    • 1406491
    • Bacteriophage lysis: mechanism and regulation. Young R, Microbiol Rev 1992 56 430 81 1406491
    • (1992) Microbiol Rev , vol.56 , pp. 430-81
    • Young, R.1
  • 7
    • 0036132523 scopus 로고    scopus 로고
    • Bacteriophage holins: Deadly diversity
    • Bacteriophage holins: deadly diversity. Young RJ, Mol Microbiol Biotechnol 2002 4 21 36
    • (2002) Mol Microbiol Biotechnol , vol.4 , pp. 21-36
    • Young, R.J.1
  • 8
    • 22544471225 scopus 로고    scopus 로고
    • Bacteriophage endolysins - Current state of research and applications
    • DOI 10.1016/j.mib.2005.06.002, PII S1369527405000767, Host-Microbe Interactions: Fungi / Parasites
    • Bacteriophage endolysins-current state of research and applications. Loessner MJ, Current Opinion in Microbiology 2005 8 480 487 10.1016/j.mib.2005. 06.002 15979390 (Pubitemid 41021911)
    • (2005) Current Opinion in Microbiology , vol.8 , Issue.4 , pp. 480-487
    • Loessner, M.J.1
  • 13
    • 0141762466 scopus 로고    scopus 로고
    • Genetically modified filamentous phage as bactericidal agents: A pilot study
    • DOI 10.1046/j.1472-765X.2003.01400.x
    • Genetically modified filamentous phage as bactericidal agents: a pilot study. Hagens S, Bläsi U, Lett Appl Microbiol 2003 37 318 323 10.1046/j.1472-765X.2003.01400.x 12969496 (Pubitemid 37186625)
    • (2003) Letters in Applied Microbiology , vol.37 , Issue.4 , pp. 318-323
    • Hagens, S.1    Blasi, U.2
  • 14
    • 4644257971 scopus 로고    scopus 로고
    • Therapy of experimental Pseudomonas infections with a nonreplicating genetically modified phage
    • DOI 10.1128/AAC.48.10.3817-3822.2004
    • Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage. Hagens S, Habel A, von Ahsen U, von Gabain A, Bläsi U, Antimicrob Agents Chemother 2004 48 3817 3822 10.1128/AAC.48.10. 3817-3822.2004 15388440 (Pubitemid 39304609)
    • (2004) Antimicrobial Agents and Chemotherapy , vol.48 , Issue.10 , pp. 3817-3822
    • Hagens, S.1    Habel, A.2    Von Ahsen, U.3    Von Gabain, A.4    Blasi, U.5
  • 16
    • 19944402594 scopus 로고    scopus 로고
    • Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model
    • DOI 10.1016/j.surg.2005.02.012, PII S0039606005001364
    • Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model. Matsuda T, Freeman TA, Hilbert DW, Duff M, Fuortes M, Stapleton PP, Daly JM, Surgery 2005 137 639 646 10.1016/j.surg.2005.02.012 15933632 (Pubitemid 40755421)
    • (2005) Surgery , vol.137 , Issue.6 , pp. 639-646
    • Matsuda, T.1    Freeman, T.A.2    Hilbert, D.W.3    Duff, M.4    Fuortes, M.5    Stapleton, P.P.6    Daly, J.M.7
  • 19
    • 0037024849 scopus 로고    scopus 로고
    • Staphylococcus aureus Resistant to Vancomycin - United States 2002
    • 12139181
    • Staphylococcus aureus Resistant to Vancomycin-United States 2002. CDC, MMWR 2002 51 565 567 12139181
    • (2002) MMWR , vol.51 , pp. 565-567
    • Cdc1
  • 20
    • 0031885229 scopus 로고    scopus 로고
    • New approaches to reduce Staphylococcus aureus nosocomial infection rates: Treating S. aureus nasal carriage
    • 9475834
    • New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Perl TM, Golub JE, Ann Pharmacother 1998 32 7 16 9475834
    • (1998) Ann Pharmacother , vol.32 , pp. 197-16
    • Perl, T.M.1    Golub, J.E.2
  • 22
    • 0038808883 scopus 로고    scopus 로고
    • The prospect for bacteriophage therapy in Western medicine
    • DOI 10.1038/nrd1111
    • The prospect for bacteriophage therapy in Western medicine. Merril CR, Scholl D, Adhya SL, Nat Rev Drug Discov 2003 2 489 497 10.1038/nrd1111 12776223 (Pubitemid 37361729)
    • (2003) Nature Reviews Drug Discovery , vol.2 , Issue.6 , pp. 489-497
    • Merril, C.R.1    Scholl, D.2    Adhya, S.L.3
  • 23
    • 0020610320 scopus 로고
    • The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage
    • The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Kreiswirth BN, Löfdahl S, Betley MJ, O'Reilly M, Schlievert PM, Bergdoll MS, Novick RP, Nature 1983 305 709 712 10.1038/305709a0 6226876 (Pubitemid 13021519)
    • (1983) Nature , vol.305 , Issue.5936 , pp. 709-712
    • Kreiswirth, B.N.1    Lofdahl, S.2    Betley, M.J.3
  • 24
    • 0025255478 scopus 로고
    • Role of upstream sequences in the expression of the Staphylococcal enterotoxin B gene
    • 2307681
    • Role of upstream sequences in the expression of the Staphylococcal enterotoxin B gene. Mahmood R, Khan SA, J Biol Chem 1990 265 4652 4656 2307681
    • (1990) J Biol Chem , vol.265 , pp. 4652-4656
    • Mahmood, R.1    Khan, S.A.2
  • 25
    • 0026634201 scopus 로고
    • Cloning of genes affecting capsule expression in Staphylococcus aureus strain M
    • 10.1111/j.1365-2958.1992.tb00872.x 1625580
    • Cloning of genes affecting capsule expression in Staphylococcus aureus strain M. Lee CY, Mol Microbiol 1992 6 1515 1522 10.1111/j.1365-2958.1992. tb00872.x 1625580
    • (1992) Mol Microbiol , vol.6 , pp. 1515-1522
    • Lee, C.Y.1
  • 26
    • 0035157966 scopus 로고    scopus 로고
    • Analysis of catabolite control protein A-dependent repression in Staphylococcus xylosus by a genomic reporter gene system
    • DOI 10.1128/JB.183.2.580-586.2001
    • Analysis of catabolite control protein A-dependent repression in Staphylococcus xylosus by a genomic reporter gene system. Jankovic I, Egeter O, Brückner R, J Bacteriol 2001 183 580 586 10.1128/JB.183.2.580-586.2001 11133951 (Pubitemid 32048116)
    • (2001) Journal of Bacteriology , vol.183 , Issue.2 , pp. 580-586
    • Jankovic, I.1    Egeter, O.2    Bruckner, R.3
  • 27
    • 0004078614 scopus 로고
    • New York: Interscience Publishers
    • Adams MH, Bacteriophages New York: Interscience Publishers 1959
    • (1959) Bacteriophages
    • Adams, M.H.1
  • 28
    • 33748779159 scopus 로고    scopus 로고
    • Working with Bacteriophages: Common Techniques and Methodological Approaches
    • CRC press Kutter E, Sulakvelidze A
    • Working With Bacteriophages: Common Techniques And Methodological Approaches. Carlson K, Bacteriophages: Biology and Applications CRC press, Kutter E, Sulakvelidze A, 2005 437 490
    • (2005) Bacteriophages: Biology and Applications , pp. 437-490
    • Carlson, K.1
  • 30
    • 0026891517 scopus 로고
    • Improved method for electroporation of Staphylococcus aureus
    • 1521761
    • Improved method for electroporation of Staphylococcus aureus. Schenk S, Laddaga RA, FEMS Microbiol Lett 1992 73 133 138 1521761
    • (1992) FEMS Microbiol Lett , vol.73 , pp. 133-138
    • Schenk, S.1    Laddaga, R.A.2
  • 32
    • 0032519353 scopus 로고    scopus 로고
    • GeneMark.hmm: New solutions for gene finding
    • DOI 10.1093/nar/26.4.1107
    • GeneMark.hmm: new solutions for gene finding. Lukashin A, Borodovsky M, Nucleic Acids Research 1998 26 1107 1115 10.1093/nar/26.4.1107 9461475 (Pubitemid 28291669)
    • (1998) Nucleic Acids Research , vol.26 , Issue.4 , pp. 1107-1115
    • Lukashin, A.V.1    Borodovsky, M.2
  • 33
    • 0021804630 scopus 로고
    • Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis
    • Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimantal gram-negative bacterial sepsis. Shenep JL, Barton RP, Mogan KA, J Infect Dis 1985 151 1012 1018 10.1093/infdis/151.6.1012 3889171 (Pubitemid 15065972)
    • (1985) Journal of Infectious Diseases , vol.151 , Issue.6 , pp. 1012-1018
    • Shenep, J.L.1    Barton, R.P.2    Mogan, K.A.3
  • 34
    • 0032777978 scopus 로고    scopus 로고
    • Antibiotic-induced cell wall fragments of Staphylococcus aureus increase endothelial chemokine secretion and adhesiveness for granulocytes
    • 10582893
    • Antibiotic-induced cell wall fragments of Staphylococcus aureus increase endothelial chemokine secretion and adhesiveness for granulocytes. Van Langevelde P, Ravensbergen E, Grashoff P, Beekhuizen H, Groeneveld PH, Van Dissel JT, Antimicrob Agents Chemother 1999 43 2984 2989 10582893
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 2984-2989
    • Van Langevelde, P.1    Ravensbergen, E.2    Grashoff, P.3    Beekhuizen, H.4    Groeneveld, P.H.5    Van Dissel, J.T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.